In summary, we demonstrate that the antitumor activity of resveratrol against osteosarcoma U2-OS cells in vitro is achieved by up-regulating Cx43 and E-cadherin expression, and suppressing the Wnt/β-catenin signaling pathway. The gene discussed is CDH1; the disease is osteosarcoma.